摘要
目的探讨腹腔镜脾切除术在各类脾脏疾病中的安全性及疗效。方法回顾分析2007年5月至2009年12月完成的55例腹腔镜脾切除术资料。其中特发性血小板减少性紫癜(1TP)11例,自身免疫性溶血性贫血6例,球形红细胞增生症1例,脾淋巴瘤1例,脾囊肿10例,脾血管瘤5例,脾脉管瘤2例,肝硬化门脉高压脾功能亢进(脾亢)患者9例,肝硬化脾亢患者9例,不明原因脾肿大脾亢1例。结果55例患者均顺利完成腹腔镜脾切除术,无中转手助或中转开腹,平均手术时间(119.7±33.0)min。术中出血量平均(83.8±65.2)ml。术后平均住院时间(5.7±1.1)d。术后腹水1例,腹腔引流液淀粉酶升高7例,无手术死亡。结论腹腔镜脾切除术能安全有效地适用于多种脾脏疾病的手术治疗。
Objective To study the safety and efficacy of laparoscopic splenectomy for splenic diseases. Method We retrospectively studied the outcomes of 55 patients who underwent laparoscopie splenectomy from May 2007 to December 2009. Splenic diseases included idiopathic thrombocytopenia purpura (n= 11), autoimmune hemolytic anemia (n = 6), hereditary spherocytosis (n = 1), splenic lymphoma (n=1), splenic cyst (n=10), splenic angioma (n=5), vascular tumor of spleen (n:2), cirrhosis, portal hypertension and hypersplenism (n = 9), cirrhosis and hyperplenism (n = 9), and idiopathic splenomegaly (n= 1). Results All patients underwent laparoscopie splenectomy, and there was no conversion to open surgery. The operation time (mean±S. D. ) was (119.7±33.0) rain. The intraoperative blood loss (mean± S. D. ) was (83.8 ± 65.2) ml, and the postoperative hospital stay (mean±S. D. ) was (5.7±1. ]) days. One patient developed postoperative ascites, and 7 patients had drain fluid rich in amylase. There was no perioperatively death. Conclusion Laparoscopic splenecto my was safe and efficacious for splenic diseases.
出处
《中华肝胆外科杂志》
CAS
CSCD
北大核心
2012年第2期85-87,共3页
Chinese Journal of Hepatobiliary Surgery
关键词
腹腔镜脾切除术
脾脏疾病
Laparoseopic splenectomy
Diseases of spleen